ArticleOncology letters2020

Akt inhibitor MK-2206 reduces pancreatic cancer cell viability and increases the efficacy of gemcitabine.

Zhanshan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.